Koninklijke Philips NV vs Tyson Foods, Inc. — how do they compare? Koninklijke Philips NV trades at $24.38 (market cap $23.68B), while Tyson Foods, Inc. trades at $52.31 (market cap $18.19B). The key difference: Koninklijke Philips NV is the larger of the two by market cap, and Koninklijke Philips NV pays the higher dividend (4.21%). Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Tyson Foods, Inc. for 76 Days on average.
| PHG | TSN | |
|---|---|---|
Market Cap | $23.68B | $18.19B |
Volume | 1,443,075 | 3,320,883 |
Sector | Health | Consumer Staples |
52-Week High | $32.91 | $68.75 |
52-Week Low | $23.81 | $50.47 |
Typical Hold Time | 84 Days | 76 Days |
Enterprise Value | $30.07B | $25.45B |
Dividend Yield | 4.21% | 3.95% |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.09, down 0.25% on the day, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong operational cash flow of $1.17B. Recent news highlights product innovations including new CT systems and AI healthcare tools, while institutional investors like Bank of America and Arrowstreet Capital have increased positions.
PHG presents a mixed outlook with solid profitability recovery but technical weakness. The stock offers value at reasonable valuations (P/E 18.84, P/S 1.18) and analyst consensus leans Hold (63.64%). Key risks include cybersecurity threats (Reuters, 2026-08-13) and debt levels, while opportunities lie in healthcare technology expansion and Exor's potential increased stake to 22% (Reuters, 2026-08-11).
Tyson Foods (TSN) trades at $51.70, down 0.52% on the day, with mixed technical signals showing neutral overall but bearish moving averages. The company reported Q2 2026 EPS of $0.99, beating expectations of $0.989, though revenue growth remains modest at 1.5%-2.0% for fiscal 2026. Valuation metrics show a P/E of 31.91 and P/S of 0.33, with analyst consensus price target at $65.40 representing 26% upside potential.
The stock presents a cautious opportunity with strong analyst support (53% buy ratings) but faces headwinds from beef segment losses and ongoing securities investigations. Upside potential exists if management can stabilize margins and execute on cost controls, though investors should monitor the Q4 earnings release on November 16, 2026 for confirmation of turnaround progress.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →